About Us

RXConnect International offers a niche range of services that can be individualised for companies contemplating entering Australian or New Zealand healthcare markets.These include: licensing and brokering of products; partner/merger/acquisition services; and sponsorship/directorship services.

With over 30 years experience and an extensive network of contacts developed locally and internationally, our professional consultants have experience at executive-management level with a proven track record of establishing healthcare products in a range of markets in Australia, New Zealand and overseas.

We pride ourselves on having a thorough knowledge of all facets of the healthcare industry. Our successes come from this understanding but also a determination to provide cost-effective solutions to our clients.

Because we have an extensive understanding of the healthcare industry locally and internationally, an extensive list of contacts and experience at executive-management level, our range of services can be critical to all businesses, whether they be start-up operations or established enterprises.

RXConnect International understands that every company has specific goals and expectations when it comes to business and market outcomes. RXConnect International is committed to offering the most efficient, cost-effective service; customising innovative solutions to meet any market-entry challenge.

Principal consultant - Mr Bruce HewettPrincipal consultant - Mr Bruce Hewett

Bruce is a registered pharmacist having graduated from Curtin University in Western Australia in 1974. As a pharmacist Bruce has worked as a hospital pharmacist (Royal Perth Hospital) before spending time in the community pharmacy sector, including 10 years in the Fiji Islands as a proprietor.

Returning to Australia in 1986 Bruce joined Janssen-Cilag in Sydney as a product specialist-biotechnology, which saw him launch Australia's first for human use biotechnology product, Orthoclone OKT-3®, for transplant rejection. With success as a product specialist, Bruce filled a variety of roles within Janssen-Cilag, including senior marketing roles as well as General Manager of the business in New Zealand.

In 1994 Bruce joined the Australian organisation Faulding Pharmaceuticals, based in Melbourne. As General Manager Australia and New Zealand Bruce was responsible for the sales and marketing of a large range of oral and injectable prescription medicines. The role involved extensive overseas travel to develop in-licensing opportunities for Australian and New Zealand markets. Deals were concluded with suppliers in the United States, Canada, United Kingdom, Sweden, France, Japan and India.

With the takeover of Faulding Pharmaceuticals Bruce took the opportunity to join Commercial Eyes Pty Ltd in 2002 as an executive director. Since it was established in 2001, Commercial Eyes has developed into one of Australia's leading healthcare industry consultancies. At Commercial Eyes Bruce specialised in the provision of licensing, brokering, merger and acquisition services, aiding overseas corporations (in particular) with their market-entry strategies.

Building upon an extensive healthcare industry network, Bruce saw the opportunity to establish a specialist pharmaceutical company in 2006, founding Max Pharma. Bruce built the business from ‘ground-zero' through to its successful acquisition in early 2009.

With over 30 years industry experience in Australia and New Zealand, much of it involving the area of licensing, brokering, mergers and acquisitions and the provision of sponsorship/directorship services, Bruce believes RXConnect International is well placed to assist clients in meeting their market-entry strategies.

Contact Us

If you are interested in our services or would like to learn more about how RXConnect can help your business please contact us using the form provided, or call today on (61) 0419 818 345.